CN102626491A - Externally used Chinese herbal medicine composition for treatment of lumbar interveterbral disc protrusion - Google Patents
Externally used Chinese herbal medicine composition for treatment of lumbar interveterbral disc protrusion Download PDFInfo
- Publication number
- CN102626491A CN102626491A CN201210120821XA CN201210120821A CN102626491A CN 102626491 A CN102626491 A CN 102626491A CN 201210120821X A CN201210120821X A CN 201210120821XA CN 201210120821 A CN201210120821 A CN 201210120821A CN 102626491 A CN102626491 A CN 102626491A
- Authority
- CN
- China
- Prior art keywords
- herbal medicine
- chinese herbal
- root
- medicine composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 15
- 241000411851 herbal medicine Species 0.000 title abstract description 10
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 title abstract 2
- 239000004863 Frankincense Substances 0.000 claims abstract description 8
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 7
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 7
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 7
- 244000170916 Paeonia officinalis Species 0.000 claims abstract description 5
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 5
- 240000001949 Taraxacum officinale Species 0.000 claims abstract description 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 4
- 241000218158 Clematis Species 0.000 claims abstract description 3
- 240000007311 Commiphora myrrha Species 0.000 claims description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 3
- 235000007351 Eleusine Nutrition 0.000 claims description 3
- 241000209215 Eleusine Species 0.000 claims description 3
- 241001071795 Gentiana Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 206010050296 Intervertebral disc protrusion Diseases 0.000 claims description 3
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 3
- 230000000699 topical effect Effects 0.000 claims description 3
- 240000002045 Guettarda speciosa Species 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 241001057584 Myrrha Species 0.000 abstract description 3
- 244000025670 Eleusine indica Species 0.000 abstract description 2
- 235000014716 Eleusine indica Nutrition 0.000 abstract description 2
- 235000014820 Galium aparine Nutrition 0.000 abstract description 2
- 241000219240 Acer pictum subsp. mono Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 241000167549 Aralia chinensis Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000501743 Gentiana macrophylla Species 0.000 abstract 1
- 241000244365 Ligusticum sinense Species 0.000 abstract 1
- 241000195954 Lycopodium clavatum Species 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 12
- 230000000202 analgesic effect Effects 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 208000012287 Prolapse Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000008765 Sciatica Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 2
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940117916 cinnamic aldehyde Drugs 0.000 description 2
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 239000008361 herbal raw material Substances 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- KYIYXWHVYGBAKF-UHFFFAOYSA-N (16R)-5beta-Hydroxy-16-methyl-lycopodan-8-on Natural products C1CCN2CCCC3C22CC(C)C(=O)C3CC(O)C21 KYIYXWHVYGBAKF-UHFFFAOYSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000269350 Anura Species 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000717739 Boswellia sacra Species 0.000 description 1
- 108090000312 Calcium Channels Proteins 0.000 description 1
- 102000003922 Calcium Channels Human genes 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- ICWQJNDZXVMLCK-JXEZDRHFSA-N Dihydrolycopodine Natural products C1CCN2CCC[C@@H]3[C@H]4C[C@@H](C)C[C@]32[C@H]1[C@H](O)C4 ICWQJNDZXVMLCK-JXEZDRHFSA-N 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010021750 Infantile Spasms Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 244000273256 Phragmites communis Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 241000053227 Themus Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001203 anti-plasmodial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000013257 developmental and epileptic encephalopathy Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- BCZFSDNVXODRAJ-JTTNIQEDSA-N lycopodine Chemical compound C1CCN2CCC[C@@H]3[C@H]4C[C@@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-JTTNIQEDSA-N 0.000 description 1
- BCZFSDNVXODRAJ-ZHMBSYLPSA-N lycopodine Natural products C1CCN2CCC[C@@H]3[C@H]4C[C@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-ZHMBSYLPSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- JEXVQSWXXUJEMA-UHFFFAOYSA-N pyrazol-3-one Chemical compound O=C1C=CN=N1 JEXVQSWXXUJEMA-UHFFFAOYSA-N 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
An externally used Chinese herbal medicine composition for treatment of lumbar interveterbral disc protrusion is characterized in that Chinese herbal medicine raw materials comprises 30 g of goosegrass, 30 g of dandelion, 20 g of Gentiana macrophylla, 25 g of Sichuan cassia twigs, 40 g of fresh Chinese aralia root bark, 20 g of Chinese angelica, 30 g of common clubmoss herb, 15 g of incised notopterygium, 30 g of pubescent angelica root, 30 g of red paeony root, 30 g of clematis root, 25 g of bark of acer monoes, 30 g of Sichuan lovage rhizome, 20 g of costus root, 30 g of frankincense, and 25 g of myrrha by weight. The Chinese herbal medicine composition has low treatment cost and a good treatment effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, refer in particular to a kind of treatment prolapse of lumbar intervertebral disc Chinese herbal medicine for external use compositions.
Background technology
Treatment stalk intercalated disc is outstanding be current comparatively general and be difficult to again cure commonly encountered diseases, frequently-occurring disease, sickness rate is higher, the course of disease is long, cure rate is low.This sick clinical manifestation is a lumbago and skelalgia, and it is limited to take action.Its because of be mostly to toil away excessively, accident gets injured by a fall, the lumbar intervertebral disc ligament is suddenly overweight to bear the damage that pulling force causes, and pad can't be recovered naturally and forms outstanding disease.For the traditional therapy of the cold disease of this type, majority all is to adopt massage, massage, sealing, traction or operative treatment, does not have special, efficacious therapy method relatively in addition.Chinese patent once disclosed " a kind of Chinese medicine composition of treating prolapse of lumbar intervertebral disc, sciatica " (China, publication number CN1413639A, open day on April 30th, 2003), was made up of Chinese liquor and Chinese medicine composition.Be monarch drug with Forsyihia viridissima Lindl, Radix Dipsaci, the Cortex Eucommiae, Caulis Spatholobi in the compositions, Radix Rhapontici, field dobber are ministerial drug, and Radix Codonopsis, the Radix Rehmanniae, Rhizoma Drynariae are adjuvant drug, add 60 degree Chinese liquor sealing room temperature lucifuges again and deposit three months after-filtration, remove slag and process.Through by different level, the effective ingredient of branch time to compositions decompose, and gives full play to the effect of compositions and the medicated wine processed is applied to clinical.The patient of prolapse of lumbar intervertebral disc, sciatica takes this medicine, and bone is endorsed slowly and automatically reset, and the sciatic nerve root no longer suffers oppression, and ligament increases elasticity makes the outstanding recurrence again that is difficult for, and effect very significantly.Through to 300 examples be diagnosed as prolapse of lumbar intervertebral disc, the sciatica patient adheres to medication, tracing observation, clinical statistics: a 1-3 course cure rate can be up to more than 70%, total effective rate 100%.
Summary of the invention
The object of the present invention is to provide a kind of treatment prolapse of lumbar intervertebral disc Chinese herbal medicine for external use compositions, medical expense is low, and therapeutic effect is good.
To achieve the above object, the present invention takes the following technical solution: A topical treatment of lumbar disc herniation herbal composition, the ratio of herbal raw material by weight: Eleusine 30, dandelion 30, Gentiana 20, Sichuan Guizhi 25, fresh root bark of Aralia Pin 40 Angelica 20, lycopodii 30, Notopterygium 15, independent living 30, red peony 30, Clematis 30, the Pentagon Paper 25, Chuanxiong 30, costas 20, 30 frankincense, myrrh 25.
The present invention is on the basis of prescription handed down from one's ancestors, and according to clinical practice, to patient's medication tracing observation, constantly the adjustment prescription forms above-mentioned Cheng Fang.Its medical expense is low, and is effective, particularly external after massaging, massage, seal, drawing, better effects if.Each Chinese herbal medicine is easy to get, and consumption is few, and price is low, and external application is convenient, and preservation is easy to carry.
The specific embodiment
Chinese herbal medicine for treating lumbar disc herniation topical composition ratio of the herbal raw material: goose grass 30g, dandelion 30g, Gentiana 20g, Chuan Gui 25g, fresh root bark of Aralia Pin 40g, angelica 20g, lycopodii 30g, Notopterygium 15g, independent living 30g, red peony root 30g, Radix 30g, Pentagon skin 25g, Chuan Xiong 30g, woody 20g, frankincense 30g, myrrh 25g.
Each Chinese herbal medicine is processed medicine cake or ointment through the science compatibility, outside massaging, massage, seal, draw later on, spreads on the affected part, gives full play to their drug effect.Their pharmacology is summarized as follows.
Herba Eleusines Indicae: be used to treat expelling wind and removing dampness, heat-clearing and toxic substances removing, the effect of waist sprain and contusion pain, eliminating stasis to stop pain, cramp, Sunstroke heating can be controlled unconsciousness due to high fever, also can prevent effect such as epidemic encephalitis type B.
Herba Taraxaci: staphylococcus aureus Resistant strain, Hemolytic streptococcus are had very strong killing action, alcohol extract can suppress tubercule bacillus can also kill leptospira, helicobacter pylori and some fungus, in addition also have antitumor, protect the liver, function of gallbladder promoting, diuresis, excitement or effects such as inhibition heart, gastric acid inhibitory secretion.
Radix Gentianae Macrophyllae: can stimulate heavy body through nervous system, make adrenocortical hormone secretion increase and realize antiinflammatory action, low dose has sedation; Heavy dose has the central excitation effect; Can reduce the Cavia porcellus blood pressure, can make heart rate subtract casual no fast imperial decree tolerance phenomenon simultaneously, blood glucose in addition in addition raises; Antianaphylaxis shock, antihistamine and but antiplasmodial effect.
Ramulus Cinnamomi: Ramulus Cinnamomi acid alcohol extract all has certain inhibitory action to staphylococcus aureus, pneumobacillus, escherichia coli, Bacillus proteus, dysentery bacterium and Bacillus typhi etc.; Aqua cinnamomi decoct and cinnamic aldehyde have analgesic, analgesic activity; This effect and expansion peripheral blood vessel, promote the diaphoresis relevant cinnamic aldehyde that dispels the heat that calm antiinflammatory and convulsions effect are arranged, and the antithrombase effect is arranged.
Bright Cortex araliae chinensis root bark: be used to treat rheumatic arthritis, lumbago and skelalgia, expelling wind and removing dampness, inducing diuresis to remove edema, promoting blood circulation and stopping pain, also effective in cure to traumatic injury.
Radix Angelicae Sinensis: the many-sided functional activity of regulating uterine smooth muscle of ability, excited or inhibition uterus can increase the myocardial blood supply, reduces myocardial oxygen consumption; Reduce vascular resistance, increase circulation volume, arrhythmia, expansion peripheral blood vessel; Bring high blood pressure down, anti-pernicious anemia effect is arranged, also can suppress.
Herba Lycopodii: Herba Lycopodii contains lycopodine; Dihydro lycopodine, Herba Lycopodii alkali, the peaceful alkali of Herba Lycopodii, remove the bright alkali of acetyl west booth, the bright alkaline matter of Fa Xiting; Herba Lycopodii water logging agent has refrigeration function, and alcohol extract has analgesic activity, also can urge the sleeping eyes time of a mice; Diuresis, urate excretion can also be removed infantile spasm property urine retention and constipation etc.
Radix Angelicae Pubescentis: antibacterial action is widely arranged, can suppress the external evoked rat serum of adenosine diphosphate (ADP) and pull gathering for a short time, have the activity of antagonism calcium channel blocker receptor, also have spasmolytic, analgesia, calmness, antiinflammatory in addition, effect such as photosensitive grade.The interior mutually vinegar of Fructus Citri Sarcodactylis has the protective effect of moderate strength to experimental gastric ulcer.
Rhizoma Et Radix Notopterygii: Rhizoma Et Radix Notopterygii has analgesic, analgesia, antiinflammatory, antiallergic, function of resisting myocardial ischemia, and arrhythmia, antithrombotic form, anti-insane pain, antioxidation, effect such as antibiotic.Plating experiment showed, has the obvious suppression effect to dysentery bacterium, escherichia coli, Bacillus typhi, bacillus pyocyaneus and staphylococcus aureus.
TPG: anti-thrombotic and anti-atherosclerosis, can inhibit the in vitro pull thrombosis and platelet aggregation, thereby regulating blood coagulation and fibrinolytic system, enhance coronary blood flow, resistance to pathogens, anti-inflammatory, sedative, solution spasm, red peony root decoction against staphylococci, hemolytic streptococcus, Streptococcus pneumoniae and dysentery Yan typhoid, colon deformation, etc., have a certain effect.
Radix Clematidis: water extract-alcohol precipitation liquid has protective effect to the rat heart muscle ischemia due to the pituitrin; The alcohol extract isolated ileum segments in guinea pigs smooth muscle that can relax; The ileum that antihistamine or second phthalein choline are caused shrinks, and water decoction is striven the Mus plasmodium to Bai Shi and dyed the obvious suppression effect is arranged.
Cortex Acanthopancis: anti-joint inflammation and analgesic activity are arranged, can strengthen the resistance of human body, radiation injury is had protective effect, antidiuretic activity is arranged, mice is had significant anti-syngignoscism to disease.Also have adjust blood pressure, blood sugar lowering, reduction vascular permeability, excited matter rabbit intestinal and uterus in addition, kill effects such as filaricide children.
Rhizoma Chuanxiong: can obviously add its coronary artery blood flow for the quiet notes CHUANSHAO of Canis familiaris L. throat; Reduce coronary resistance; Promote the tremulous pulse microcirculation; Blood pulled to assemble for a short time has depolymerisation, the myocardial oxygen delivery of improvement is arranged and significantly holds persistent hypotensive effect, quiet notes CHUANSHAO crash rabbit whole blood slitted degree and RCD all have improvement, the seat thing that can suppress thromboxane A2 is synthetic and active.
The Radix Aucklandiae: the effect of spasm due to pair anti-acetylcholine and the histamine is arranged, the little Yang that exsomatizes is had slight excitation, tonicity and rhythmicity friend show and reduce subsequently, to the stripped frogs.The heart has inhibitory action, and low dose can expand long rabbit ear pipe, brings high blood pressure down, and can suppress streptococcus, and the growth of golden yellow and Staphylococcus albus has antibacterial action.
Frankincense: anti-inflammatory, analgesic, rat reeds clothes boswellic acids, can make the skin, liver, kidney and spleen glycosaminoglycan synthesis decreased for duodenal ulcer, frankincense mixed in corn oil by oral a month can effectively reduce aspirin, pyrazolone and flooding emergency department gastric ulcer in rats sticky Mo injury, mice fed frankincense have significant analgesic effect.
Myrrha: transfer blood fat, blood fat reducing and lipolytic effect arranged, and can suppress the synthetic of liver sentence slurry cholesterol, antiinflammatory with bring down a fever acute lumbar muscle sprain, breast does not have each equal portions of paste Olibanum Myrrha to grind into powder, with the furnishing pasty state external of will adding medicine to of 30% ethanol certain curative effect is arranged.
This medicine is treated 354 routine patients; Wherein fat male surname 135 examples, thin male surname 86 examples, fat women surname 82 examples, thin women surname 51 examples are adhered to 307 examples that have of treating, healing reach 100% example; The obese patient cured about about 28 days to 45 days, and thin patient cured about about 12 days to 21 days.
Claims (1)
1 A topical treatment of lumbar disc herniation herbal composition, wherein the ratio by weight of the herbal ingredients are: Eleusine 30, dandelion 30, Gentiana 20, Sichuan Guizhi 25, fresh root bark of Aralia Pin 40, Angelica 20, lycopodii 30, Notopterygium 15, independent living 30, red peony 30, Clematis 30, the Pentagon Paper 25, Chuanxiong 30, costas 20, 30 frankincense, myrrh 25.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210120821 CN102626491B (en) | 2012-04-10 | 2012-04-10 | Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210120821 CN102626491B (en) | 2012-04-10 | 2012-04-10 | Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102626491A true CN102626491A (en) | 2012-08-08 |
| CN102626491B CN102626491B (en) | 2013-12-18 |
Family
ID=46584999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210120821 Expired - Fee Related CN102626491B (en) | 2012-04-10 | 2012-04-10 | Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102626491B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103859393A (en) * | 2012-12-13 | 2014-06-18 | 广州白云山中一药业有限公司 | Food and preparation method and application thereof |
-
2012
- 2012-04-10 CN CN 201210120821 patent/CN102626491B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 薛怀宝: "中医药治疗腰椎间盘突出症近况", 《贵阳中医学院学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103859393A (en) * | 2012-12-13 | 2014-06-18 | 广州白云山中一药业有限公司 | Food and preparation method and application thereof |
| CN103859393B (en) * | 2012-12-13 | 2015-08-19 | 广州白云山中一药业有限公司 | A kind of food and its preparation method and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102626491B (en) | 2013-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102205026B (en) | Chinese medicinal composition for treating children chronic sinusitis and preparation method thereof | |
| CN101428097A (en) | Psoriasis treating Chinese medicine preparation and its preparing process | |
| CN104491052B (en) | Traditional Chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method thereof | |
| CN101919944B (en) | Traditional Chinese medicine compound, preparation method and application thereof | |
| CN104258278A (en) | Gushangling (for bone injury) spray | |
| CN103877247A (en) | Medicine for treating bedsore and preparation method thereof | |
| CN101391065B (en) | Compound momordica seed pepper soup for treating urgent chronic pelvic inflammatory disease | |
| CN103566238A (en) | Traditional Chinese medicine stone removing pill for treating stones | |
| CN102626491B (en) | Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion | |
| CN102949643B (en) | Ointment for skin nursing and dermatitis treatment | |
| CN105232849A (en) | Plaster for treating burns | |
| CN105456923A (en) | Traditional Chinese medicine composition with efficacy of removing stasis to ease pain and preparation method of traditional Chinese medicine composition | |
| CN101474329B (en) | Moschus skin recovery paste for treating damaged skin | |
| CN100355437C (en) | Medicine for treating scald and burn and preparing method | |
| CN104825598A (en) | External-use plaster for treating rheumatic bone pain and preparation method thereof | |
| CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
| CN112022933B (en) | Pharmaceutical composition for treating stomachache with syndrome of qi stagnation and blood stasis | |
| CN109010447A (en) | For the traditional Chinese medicine dressing and its preparation of hot numbness pain wind and application | |
| CN102526544B (en) | Oral powder Chinese medicine formula for treating lumbar disc herniation and osteoproliferation | |
| CN102626479B (en) | External-use Chinese herbal medicine composition for chronic rheumatism treatment | |
| CN105362944A (en) | Traditional Chinese medicine ointment for treating orthopedics sprain and contusion | |
| CN104888147A (en) | Traditional Chinese medicine ointment for shoulder periarthritis and preparation method thereof | |
| CN105535853A (en) | Traditional Chinese medicine composition for treating bedsores for clinical nursing | |
| CN105232664A (en) | Plaster for external application to sciatic nerves | |
| CN105012470A (en) | Medicine liquor for treating cervical cancer complication radiation proctitis through coloclysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131218 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |